BACKGROUND: A common missense variant of the CDKN2A gene (A148T) predisposes to malignant melanoma in Poland. An association between malignant melanoma and breast cancer has been reported in several families with CDKN2A mutations, OBJECTIVE: To determine whether this variant also predisposes to breast cancer. METHODS: Genotyping was undertaken in 4209 cases of breast cancer, unselected for family history, from 18 hospitals throughout Poland and in 3000 controls. RESULTS: The odds ratio (OR) associated with the CDKN2A allele for women diagnosed with breast cancer before the age of 50 was 1.5 (p = 0.002) and after age 50 it was 1.3 (p = 0.2). The effect was particularly strong for patients diagnosed at or before the age of 30 (OR = 3.8; p = 0.0002). CONCLUSIONS: CDKN2A appears to be a low penetrance breast cancer susceptibility gene in Poland. The association should be confirmed in other populations.
BACKGROUND: A common missense variant of the CDKN2A gene (A148T) predisposes to malignant melanoma in Poland. An association between malignant melanoma and breast cancer has been reported in several families with CDKN2A mutations, OBJECTIVE: To determine whether this variant also predisposes to breast cancer. METHODS: Genotyping was undertaken in 4209 cases of breast cancer, unselected for family history, from 18 hospitals throughout Poland and in 3000 controls. RESULTS: The odds ratio (OR) associated with the CDKN2A allele for women diagnosed with breast cancer before the age of 50 was 1.5 (p = 0.002) and after age 50 it was 1.3 (p = 0.2). The effect was particularly strong for patients diagnosed at or before the age of 30 (OR = 3.8; p = 0.0002). CONCLUSIONS:CDKN2A appears to be a low penetrance breast cancer susceptibility gene in Poland. The association should be confirmed in other populations.
Authors: Chandra G Bertram; Rupert M Gaut; Jennifer H Barrett; Elizabeth Pinney; Linda Whitaker; Faye Turner; Veronique Bataille; Isabel Dos Santos Silva; Anthony J Swerdlow; D Timothy Bishop; Julia A Newton Bishop Journal: J Invest Dermatol Date: 2002-10 Impact factor: 8.551
Authors: N Burri; P Shaw; H Bouzourene; I Sordat; B Sordat; M Gillet; D Schorderet; F T Bosman; P Chaubert Journal: Lab Invest Date: 2001-02 Impact factor: 5.662
Authors: A Borg; T Sandberg; K Nilsson; O Johannsson; M Klinker; A Måsbäck; J Westerdahl; H Olsson; C Ingvar Journal: J Natl Cancer Inst Date: 2000-08-02 Impact factor: 13.506
Authors: Tadeusz Debniak; Rodney J Scott; Tomasz Huzarski; Tomasz Byrski; Andrzej Rozmiarek; Bogusław Debniak; Elzbieta Załuga; Romuald Maleszka; Józef Kładny; Bohdan Górski; Cezary Cybulski; Jacek Gronwald; Grzegorz Kurzawski; Jan Lubinski Journal: Cancer Res Date: 2005-02-01 Impact factor: 12.701
Authors: Robert Smigiel; Maria Sasiadek; Tomasz Krecicki; David Ramsey; Jozef Jagielski; Nikolaus Blin Journal: Mol Carcinog Date: 2004-03 Impact factor: 4.784
Authors: Tadeusz Debniak; Bohdan Górski; Rodney J Scott; Cezary Cybulski; Krzysztof Medrek; Elzbieta Zowocka; Grzegorz Kurzawski; Boguslaw Debniak; Józef Kadny; Stanislawa Bielecka-Grzela; Romuald Maleszka; Jan Lubiński Journal: Int J Cancer Date: 2004-07-01 Impact factor: 7.396
Authors: A H Prowse; D C Schultz; S Guo; L Vanderveer; J Dangel; B Bove; P Cairns; M Daly; A K Godwin Journal: J Med Genet Date: 2003-08 Impact factor: 6.318
Authors: Bhramar Mukherjee; John Oliver Delancey; Leon Raskin; Jessica Everett; Joanne Jeter; Colin B Begg; Irene Orlow; Marianne Berwick; Bruce K Armstrong; Anne Kricker; Loraine D Marrett; Robert C Millikan; Hoda Anton Culver; Stefano Rosso; Roberto Zanetti; Peter A Kanetsky; Lynn From; Stephen B Gruber Journal: J Natl Cancer Inst Date: 2012-04-24 Impact factor: 13.506
Authors: Robert R McWilliams; Eric D Wieben; Kari G Rabe; Katrina S Pedersen; Yanhong Wu; Hugues Sicotte; Gloria M Petersen Journal: Eur J Hum Genet Date: 2010-12-08 Impact factor: 4.246
Authors: Michael S Cunnington; Mauro Santibanez Koref; Bongani M Mayosi; John Burn; Bernard Keavney Journal: PLoS Genet Date: 2010-04-08 Impact factor: 5.917
Authors: A M Goldstein; S N Stacey; J H Olafsson; G F Jonsson; A Helgason; P Sulem; B Sigurgeirsson; K R Benediktsdottir; K Thorisdottir; R Ragnarsson; J Kjartansson; J Kostic; G Masson; K Kristjansson; J R Gulcher; A Kong; U Thorsteinsdottir; T Rafnar; M A Tucker; K Stefansson Journal: J Med Genet Date: 2008-01-04 Impact factor: 6.318